ACH-000029 / Otsuka, Ache Lab  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ACH-000029 / Ache Lab, Otsuka
NCT05363839: To Assess the Safety, Tolerability and Pharmacokinetics of ACH-000029 in Healthy Subjects

Terminated
1
8
RoW
ACH-000029, Placebo, Matching Placebo
Syneos Health, Otsuka Pharmaceutical Development & Commercialization, Inc.
Healthy Volunteers
11/22
11/22

Download Options